GlassScriptPhysician profile
Deborah Soto
NPI 1083241582
$718.21
in general payments reported to CMS, 2019-2025
13 companies · $109 in 2025
The $109 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $39.68 · 2022: $242 · 2023: $328 · 2025: $109.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $436.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $436.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $158.47 | 2022-2023 | Mounjaro |
| Abbott Laboratories | $129.61 | 2023-2025 | Supera, Ultreon, Freestyle Libre |
| Astrazeneca Pharmaceuticals LP | $126.19 | 2022-2023 | Breztri, Farxiga |
| Cvrx, INC. | $54.56 | 2022-2023 | Barostim Neo System |
| Glaxosmithkline, LLC. | $44.91 | 2023 | Shingrix, Trelegy Ellipta |
| Novo Nordisk INC | $38.62 | 2021-2022 | |
| Horizon Therapeutics Plc | $36.59 | 2022 | |
| Sanofi-Aventis U.S. LLC | $35.98 | 2022-2023 | |
| Almatica Pharma LLC | $20.65 | 2021 | |
| Pfizer INC. | $19.69 | 2023 | |
| Dexcom, INC. | $18.96 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.89 | 2023 | Glyxambi, Synjardy, Jardiance |
| Philips North America LLC | $15.09 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deborah Soto listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.